Document is current
Any future updates will be listed below
-
Authors
,
López-González, Francisco Javier
Moscoso, Alexis
Efthimiou, Nikos
Fernández-Ferreiro, Anxo
Piñeiro-Fiel, Manuel
Archibald, Stephen J.
Aguiar, Pablo http://orcid.org/0000-0002-7322-2195
Silva-Rodríguez, Jesús
-
Funding
Funding for this research was provided by:
ISCIII (pi16/01416)
Ramón y Cajal (ryc-2015/17430)
- License Information
-
More Information
Article History
Received: 6 July 2019
Accepted: 25 October 2019
First Online: 19 December 2019
Ethics approval and consent to participate
: The ADNI2 studies were conducted according to Good Clinical Practice guidelines, US 21CFR Part 50–Protection of Human Subjects, and Part 56–Institutional Review Boards (IRBs)/Research Ethics Boards (REBs), and pursuant to state and federal HIPAA regulations. Written informed consent for the study was obtained from all participants and/or authorized representatives.
: Not applicable.
: JSR is an employee for Qubiotech Health Intelligence SL (). All other authors declare that they have no competing interests.
